Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Thursday broker round-up

Thu, 27th Jun 2019 11:16
(Sharecast News) - Rightmove: UBS downgrades to sell with a target price of 505p.Codemasters Group: Berenberg reiterates buy with a target price of 290p.Senior: Barclays downgrades to equal weight with a target price of 210p.Electrocomponents: Barclays reiterates equal weight with a target price of 640p.Rentokil: Barclays reiterates overweight with a target price of 410p.Countryside Properties: Jefferies reiterates buy with a target price of 422p.Homeserve: JP Morgan reiterates overweight with a target price of 1,350p.Just Eat: JP Morgan reiterates underweight with a target price of 600p.Hochschild Mining: RBC Capital Markets reiterates outperform with a target price of 260p.AstraZeneca: Liberum reiterates hold with a target price of 6,400p.Mind Gym: Liberum reiterates buy with a target price of 170p.Abcam: Peel Hunt downgrades to add with a target price of 1,550p.Bloomsbury: Peel Hunt reiterates buy with a target price of 300p.Staffline Group: Berenberg downgrades to hold with a target price of 150p.Premier Oil: Berenberg reiterates buy with a target price of 130p.

Related News

LONDON BROKER RATINGS: Goldman likes Autotrader, neutral on Rightmove
8 hours ago

LONDON BROKER RATINGS: Goldman likes Autotrader, neutral on Rightmove

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

LONDON BRIEFING: CMC profit jumps; Hg increases investment in HgT
9 hours ago

LONDON BRIEFING: CMC profit jumps; Hg increases investment in HgT

(Alliance News) - CMC Markets reports higher annual profit and lifts its dividend, Hg plans to increase its stake in HgCapital Trust, and S4 Capital u...

'It's still working': More are living with cancer as era of targeted drugs takes hold
1 day ago

'It's still working': More are living with cancer as era of targeted drugs takes hold

* Targeted therapies drive rising cancer survival rates, experts say

ABC.L News

RBC Capital Markets downgrades Abcam to 'sector perform'
20 Jun 2023

RBC Capital Markets downgrades Abcam to 'sector perform'

(Sharecast News) - RBC Capital Markets downgraded Abcam on Tuesday to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as i...

Broker tips: Ocado, Abcam
20 Jun 2023

Broker tips: Ocado, Abcam

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p...

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose
11 Jun 2023

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose

(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in orde...

Abcam delisting from AIM going ahead this week
12 Dec 2022

Abcam delisting from AIM going ahead this week

(Sharecast News) - Life science research tool specialist Abcam updated the market on the cancellation of its shares on AIM on Monday, which it first a...

TOP NEWS: AIM to lose largest listing as Abcam to trade only on Nasdaq
17 Oct 2022

TOP NEWS: AIM to lose largest listing as Abcam to trade only on Nasdaq

(Alliance News) - Abcam PLC on Monday proposed delisting from AIM in London and retaining a sole listing on Nasdaq in New York.

LONDON BRIEFING: Vodafone, Altice team; Hargreaves Lansdown CEO to go
17 Oct 2022

LONDON BRIEFING: Vodafone, Altice team; Hargreaves Lansdown CEO to go

(Alliance News) - Stocks in London are called a touch lower on Monday, though the pound was on the up, despite the prospect of more UK political uncer...

LONDON BROKER RATINGS: Stifel downgrades IAG, easyJet and Ryanair
14 Sep 2022

LONDON BROKER RATINGS: Stifel downgrades IAG, easyJet and Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

IN BRIEF: Abcam interim profit falls by 20% as expenses rise
12 Sep 2022

IN BRIEF: Abcam interim profit falls by 20% as expenses rise

Abcam PLC - Cambridge-based life science research software firm - Posts lower profit for six months that ended June 30 as expenses increase. Pretax pr...